Search - tctmd.com

Displaying 941 - 960 of 1203

Sort: Relevancy | Date

News Daily News

CTA Not Justified to Risk Stratify Patients Without Chest Pain

L.A. McKeown

June 18, 2012

News Daily News

Carotid Stenting, Surgery Equivalent in Patients with Contralateral Occlusion

Yael L. Maxwell

June 13, 2012

News Daily News

After TAVR, Women Show Faster LV Recovery Than Men

L.A. McKeown

June 11, 2012

News Daily News

Left, Right Radial Procedures Equally Effective, but Right Access Takes Longer

Jason Kahn

June 08, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Daily News

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

L.A. McKeown

May 29, 2012

News Industry News

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

May 25, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

Jason Kahn

May 16, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Caitlin E. Cox

May 15, 2012

News Daily News

Compared with CABG, Fewer Elective PCI Procedures Deemed Appropriate by ACCF Criteria

May 15, 2012

News Industry News

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

May 15, 2012

News Industry News

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

May 14, 2012

News Conference News

Study Examines Influence of Baseline Factors on Outcomes After CABG, PCI

L.A. McKeown

May 11, 2012

News Industry News

CID SpA Sponsors a Major Symposium at Euro PCR 2012

May 10, 2012

News Daily News

Several Factors Behind False-Positive STEMI Activations

Yael L. Maxwell

May 09, 2012

Advertisement

CTA Not Justified to Risk Stratify Patients Without Chest Pain

Carotid Stenting, Surgery Equivalent in Patients with Contralateral Occlusion

After TAVR, Women Show Faster LV Recovery Than Men

Left, Right Radial Procedures Equally Effective, but Right Access Takes Longer

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Compared with CABG, Fewer Elective PCI Procedures Deemed Appropriate by ACCF Criteria

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

Study Examines Influence of Baseline Factors on Outcomes After CABG, PCI

CID SpA Sponsors a Major Symposium at Euro PCR 2012

Several Factors Behind False-Positive STEMI Activations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content